SLU-PP-332 Research: ERR Agonism, Mouse Models, and Open Questions
SLU-PP-332 Research: ERR Agonism, Mouse Models, and Open Questions
A primary-study review of a synthetic small-molecule ERR agonist, with cell and mouse findings separated from human-cell observations.
A small-molecule ERR agonist, not a peptide
SLU-PP-332 is a synthetic small molecule described as an agonist of estrogen-related receptors, with strongest reported activity at ERRα. The receptor family’s name does not mean ordinary estrogen-receptor signaling.
The initial studies used reporter assays, skeletal-muscle cells, pharmacokinetic work, and mouse experiments. A later pilot study exposed primary myoblast cultures derived from inactive women to SLU-PP-332; that is human-derived cell evidence, not an intervention trial in people.
The phrase exercise mimetic refers to selected molecular programs or experimental endpoints. It does not establish equivalence to exercise, human performance, or human safety.
What researchers are trying to understand
Is the compound classified accurately?
Describe SLU-PP-332 as a synthetic small molecule rather than a peptide.
What does ERR agonism mean here?
Tie receptor activity to the reporter, cell, or animal experiment that measured it and avoid implying universal selectivity.
Are human data direct?
Human-derived primary cells are an in-vitro model and are not the same as a study that exposes participants to the compound.
Notable studies, in plain English
The studies below are separated by model and design so that early laboratory signals are not confused with evidence from people.
Synthetic ERRα/β/γ Agonist Induces an ERRα-Dependent Acute Aerobic Exercise Response and Enhances Exercise Capacity
- Model
- ERR reporter assays, C2C12 cells, pharmacokinetic experiments, and wild-type or ERRα-dependent mice
- Design
- Chemical-probe characterization with cell and mouse experiments
What the paper reported: Identified SLU-PP-332 as an ERRα/β/γ agonist with strongest activity at ERRα and reported cellular-respiration, oxidative-fiber, and mouse-endurance findings.
Important limit: Early cell and mouse work does not establish human safety, efficacy, or equivalence to exercise.
A Synthetic ERR Agonist Alleviates Metabolic Syndrome
- Model
- Diet-induced obese and ob/ob mice
- Design
- Intervention experiments in two mouse metabolic-disease models
What the paper reported: Reported changes in energy expenditure, substrate oxidation, body composition, and insulin sensitivity in the tested mice.
Important limit: Two mouse models provide no direct human outcome or long-term safety evidence.
Targeting ERRs to counteract age-related muscle atrophy associated with physical inactivity: a pilot study
- Model
- Primary myoblast cultures derived from inactive women undergoing hip arthroplasty
- Design
- Small donor study with ex-vivo tissue characterization and in-vitro SLU-PP-332 exposure
What the paper reported: Reported changes in oxidative-stress, senescence, expression, and myotube-formation measures in treated donor-derived cells.
Important limit: The sample was small and selected; activity was self-reported, and treating isolated cells is not a human intervention trial.
What the evidence does—and does not—establish
Most direct SLU-PP-332 evidence is preclinical, and the originating studies use selected cell systems and mouse models. Long-term selectivity, toxicology, and translation remain unresolved.
The 2025 study adds human-derived cell observations but not exposure or outcomes in participants. It should never be summarized as a human efficacy or safety study.
- SLU-PP-332 is a small molecule, not a peptide.
- It is described as a pan-ERR agonist with strongest reported activity at ERRα.
- Published direct evidence is largely cellular and animal.
- Exercise-mimetic language describes selected experimental similarities, not equivalence.
Where to buy SLU-PP-332 for laboratory research in the USA
Confirm the exact structure, formula, molecular mass, physical form, and lot. A peptide label or an exercise-oriented label is not a chemical identity.
Request lot-specific identity and quantitative assay evidence, a stated impurity method, and residual-solvent information where relevant. Preserve the report and supplier specifications with the study record.
Searches such as “where to buy SLU-PP-332,” “buy SLU-PP-332 USA,” and “USA peptides” should be treated as laboratory-sourcing questions. Compare U.S. research suppliers by lot traceability, identity testing, quantitative-content information, analytical methods, and stated research-use restrictions—not by implied human outcomes.
SLU-PP-332 research FAQ
Is SLU-PP-332 a peptide?
No. It is a synthetic small molecule.
What does ERR stand for?
Estrogen-related receptor, a family of nuclear receptors involved in metabolic gene regulation.
Does exercise mimetic mean the compound equals exercise?
No. The term describes selected experimental similarities.
Are the donor-cell findings a human trial?
No. The compound was studied in primary cells isolated from donors, not administered to participants.
What should the lot record identify?
Exact structure and form, lot, identity method, assay, impurities, and relevant residual-solvent testing.
Primary references
References link to the original journal record or publisher page. Inclusion is not an endorsement of a product or a clinical conclusion.